Photoselective green light laser vaporisation traditional transurethral resection benign prostate hyperplasia meta-analysis

Antifibrinolytic Agents/*administration & dosage Blood Loss Surgical/*prevention & control Blood Transfusion/statistics & numerical data Humans Incidence Male Prostatectomy/*adverse effects Prostatic Hyperplasia/surgery Prostatic Neoplasms/surgery Thromboembolism/*epidemiology/etiology Tranexamic Acid/*administration & dosage *Anesthesia *Blood loss *Prostate *Review *Surgical *Systematic *Tranexamic acid

Finasteride benign prostatic hyperplasia meta-analysis

Humans Laser Coagulation Laser Therapy Lasers Solid-State Male Non-Randomized Controlled Trials as Topic/statistics & numerical data Prostatic Hyperplasia/complications Quality of Life Randomized Controlled Trials as Topic/statistics & numerical data *Thulium Transurethral Resection of Prostate Treatment Outcome Ureteral Obstruction/etiology 2-micron Benign prostatic obstruction Plasmakinetic resection of prostate Safety and efficacy Thulium laser VapoResection of the prostate Thulium laser Transurethral resection of the prostate

Bph Srd5a2 polymorphism risk susceptibility

Finasteride Dutasteride Benign Prostatic Hyperplasia Meta-Analysis

*Alleles Ethnicity/genetics *Genetic Association Studies *Genetic Predisposition to Disease Genotype Humans Male Odds Ratio *Polymorphism Single Nucleotide Prostate-Specific Antigen/*genetics Prostatic Hyperplasia/*genetics Publication Bias Risk Factors Bph Psa meta-analysis polymorphism

5-alpha Reductase Inhibitors/pharmacology Blood Loss Surgical/*prevention & control Blood Transfusion Dutasteride/*pharmacology Hemoglobins/analysis Humans Male Microcirculation Prospective Studies Prostate Prostatic Hyperplasia Randomized Controlled Trials as Topic Retrospective Studies *Transurethral Resection of Prostate Treatment Outcome Vascular Endothelial Growth Factor A/metabolism Benign prostatic hyperplasia Dutasteride Intraoperative blood loss Meta-analysis Transurethral resection of the prostate

Benign prostatic hyperplasia Lower urinary tract symptoms systematic review

Tamsulosin Benign Prostatic Hyperplasia Meta Analysis

Prostatic Arterial Embolization Benign Prostate Hyperplasia Lower Urinary Tract Symptoms Meta-Analysis

Benign Prostatic Hyperplasia Lower Urinary Tract Symptoms Meta-analysis

benign prostatic hyperplasia treatment systematic review

Transurethral enucleation of the prostate transvesical open prostatectomy benign prostatic hyperplasia meta-analysis

5-alpha reductase inhibitors alpha-blockers BPH meta-analysis

Embolization Therapeutic Humans Lower Urinary Tract Symptoms/*therapy Male Prostate/*blood supply Prostatic Hyperplasia/physiopathology/*therapy benign prostatic hyperplasia lower urinary tract symptoms meta-analysis prostate artery embolization

*Arteries/diagnostic imaging Embolization Therapeutic Humans Kallikreins/blood Male Prostate/*blood supply Prostate-Specific Antigen/blood Prostatic Hyperplasia/diagnostic imaging/*therapy Quality of Life Time Factors Treatment Outcome

5-Ari + Alpha - Blockers BPH Meta-Analysis

Humans Immune Checkpoint Inhibitors/therapeutic use *Carcinoma Transitional Cell/drug therapy *Urinary Bladder Neoplasms/drug therapy Proportional Hazards Models Eastern Cooperative Oncology Group Immune checkpoint inhibitor Performance status Urothelial carcinoma

Bladder-sparing strategy Clinical complete response Localized muscle-invasive bladder cancer Neoadjuvant Systemic treatment